Infectious Diseases Search
Infectious Diseases Infectious Diseases
dengue
DENGUE

Dengue infection is caused by the dengue virus that belongs to the family Flaviviridae. It is generally self-limiting and rarely fatal.
There are 4 serotypes (DEN-1, DEN-2, DEN-3, DEN-4). Infection w/ dengue serotype confers lifetime protective immunity to that specific serotype; cross-protection for other serotypes is only short-term.
It is transmitted to humans through the bites of infected Aedes mosquitoes. It is primarily transmitted by female Aedes aegypti, a tropical and subtropical species.Humans & monkeys are the amplifying hosts after the mosquito bite.
After 4-10 days of incubation period, illness begins immediately.
The acute phase of illness lasts for 3-7 days, but the convalescent phase may be prolonged for a week and may be associated with weakness and depression especially in adults.

Dengue Drug Information

Drug Information

Indication: Relief of mild to moderate pain & fever.

Indication: Hypoalbuminaemia caused by albumin deficiency (eg, burn, Nephrose syndrome) & dysfunction of albumin synth...

Actimol Menstrual
pamabrom + paracetamol

Indication: Symptomatic relief of bloating, water-wt gain, backache, muscular aches, pre-menstrual & menstrual discomf...

Indication: Restoration & maintenance of circulating blood vol.

Indication: Shock, burns, hypoproteinaemia, hyperbilirubinaemia, cardiopulmonary bypass procedures.

Indication: Mild to moderate pain & fever.

Indication: Relief of fever & pain eg, headache, toothache, colds, flu, muscular rheumatism, dysmenorrhoea, teething p...

Indication: Relief of painful & febrile conditions eg, headache, migraine, backache, toothache, aches due to cold &...

Indication: Symptomatic relief of mild to moderate pain & fever.

Indication: Relief of mild to moderate pain & fever.

1  /  7
1  /  7
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Infectious Diseases - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
High morbidity and mortality among COVID-19 patients with haematologic malignancies
Natalia Reoutova, 2 days ago

Patients with coronavirus disease 2019 (COVID-19) who have haematologic malignancies have a 28 percent mortality rate, according to data collected from 250 patients by the ASH Research Collaborative COVID-19 presented at the 62nd American Society of Hematology Annual Meeting and Exposition (ASH 2020).
Evidence-based intervention fails to reduce haemodialysis catheter-related bloodstream infection
Roshini Claire Anthony, 01 Dec 2020

An evidence-based, multifaceted intervention aimed at reducing haemodialysis catheter-related bloodstream infections (HD-CRBSIs) failed to improve this outcome, results of the REDUCCTION* trial showed.
Adherence to physical distancing measures depends on social closeness
Tristan Manalac, 2 days ago
People are more likely to follow social distancing measures for the novel coronavirus disease (COVID-19) pandemic when they thought that their friends and family did the same, too, according to a new study.
Cancer patients on chemotherapy at high risk of severe COVID-19 complications
Stephen Padilla, 04 Dec 2020
A retrospective study in a single centre in the Philippines has found that cancer patients with recent anticancer treatment, particularly chemotherapy, and who tested positive for the novel coronavirus disease (COVID-19) have higher rates of severe complications. In addition, these patients tend to acquire infection in the hospital, which then leads to an increased risk of severe illness.